Big News Gains: Agrium (NYSE:AGU), Alcatel Lucent SA (NYSE:ALU), Cadiz (NASDAQ:CDZI), Johnson & Johnson (NYSE:JNJ)

Posted by on Oct 19, 2015

Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) shares moved up 0.42% in last trading session and ended the day at $16.60. MNTA has a return on assets of -22.70%. Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) quarterly performance is -27.48%.

Leerink Swann reissued their outperform rating on shares of Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) in a research report released on Tuesday, ARN reports. Leerink Swann currently has a $25.00 price target on the biotechnology company’s stock, down from their previous price target of $26.00.

Agrium Inc. (NYSE:AGU) ended the last trading day at $94.89. Company weekly volatility is calculated as 2.15% and price to cash ratio as 20.98. Agrium Inc. (NYSE:AGU) showed a weekly performance of -0.50%.

Agrium Inc. (NYSE:AGU) said that, it plans to release their third quarter earnings results on Thursday, November 5, 2015 before markets open. The Company plans to host a conference call to discuss the results on November 5, 2015 at 9:30 a.m. MST (11:30 a.m. EST).

Alcatel Lucent SA (ADR) (NYSE:ALU) shares advanced 0.53% in last trading session and ended the day at $3.78. ALU Gross Margin is 34.50% and its has a return on assets of 0.20%. Alcatel Lucent SA (ADR) (NYSE:ALU) quarterly performance is 5.29%.

On 12 October, Alcatel Lucent SA (ADR) (NYSE:ALU) said that, BT (NYSE: BT) is moving forward with its strategy to get ultra-fast broadband technology deployed in select parts of the United Kingdom in the near future. The carrier is working with Alcatel-Lucent (NYSE: ALU) on a consumer test of G.fast, a technology that can enable broadband speeds up to 330 Mbps over copper, in Gosforth, located in northeast England.

Cadiz Inc. (NASDAQ:CDZI) shares moved up 8.93% in last trading session and ended the day at $3.78. CDZI has a return on assets of -32.30%. Cadiz Inc. (NASDAQ:CDZI) quarterly performance is -56.20%.

On 16 October, Cadiz Inc. (NASDAQ:CDZI) posted additional information to its website about the next steps for the Cadiz Valley Water Conservation, Recovery & Storage Project (“Project”) following guidance received last week from the California State Office of the U.S. Bureau of Land Management related to plans to construct the Project’s pipeline within an active railroad right-of-way.

Johnson & Johnson (NYSE:JNJ) caters to the Healthcare space. It has a net profit margin of 20.90% and weekly performance is 2.03%. On the last day of trading company shares ended up at $97.94. Johnson & Johnson (NYSE:JNJ) distance from 50-day simple moving average (SMA50) is 3.37%.

On 9 October, Johnson & Johnson (NYSE:JNJ) has begun clinical trials for an Ebola vaccine in Sierra Leone. The vaccine regimen is part of a new study being conducted in that nation’s Kambia district, where some of the country’s most recent Ebola cases have been reported.

Leave a Reply

Your email address will not be published. Required fields are marked *